Foo, J., Chmielecki, J., Pao, W., & Michor, F. (2012). Effects of Pharmacokinetic Processes and Varied Dosing Schedules on the Dynamics of Acquired Resistance to Erlotinib in EGFR-Mutant Lung Cancer.
Chicago Style CitationFoo, Jasmine, Juliann Chmielecki, William Pao, i Franziska Michor. Effects of Pharmacokinetic Processes and Varied Dosing Schedules On the Dynamics of Acquired Resistance to Erlotinib in EGFR-Mutant Lung Cancer. 2012.
Cita MLAFoo, Jasmine, Juliann Chmielecki, William Pao, i Franziska Michor. Effects of Pharmacokinetic Processes and Varied Dosing Schedules On the Dynamics of Acquired Resistance to Erlotinib in EGFR-Mutant Lung Cancer. 2012.
Atenció: Aquestes cites poden no estar 100% correctes.